Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrinogen injection for bleeding reduction after CABG
IRCT20180909040979N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Sep 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in Bleeding comparing Fibrinogen with Placebo (2 arms). Primary endpoint: Bleeding after surgery. Started Sep 2018; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
Bleeding
Beyond the preview
Go deeper on IRCT20180909040979N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180909040979N1.